IVUS-XPL Trial Demonstrates Reduction in MACE up to 5 Years with IVUS Guidance Compared with Angiography Alone
The IVUS-XPL trial showed for the first time that the use of intravascular ultrasound (IVUS) during percutaneous coronary intervention (PCI) results in lower rates of major adverse cardiac events compared to angiography-alone-guided PCI up to 5 years, according to results presented Sunday at Transcatheter Cardiovascular Therapeutics in San Francisco.